Computed tomography findings of idiopathic multicentric Castleman disease subtypes
-
- Iguchi Toshihiro
- Department of Radiological Technology, Faculty of Health Sciences, Okayama University, Okayama, Japan, Department of Radiology, Okayama University Hospital, Okayama, Japan,
-
- Nishikori Asami
- Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan,
-
- Sato Yasuharu
- Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan,
-
- Nishimura Midori Filiz
- Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan,
-
- Iwaki Noriko
- Department of Hematology, National Cancer Center Hospital, Tokyo, Japan,
-
- Kojima Katsuhide
- Department of Radiology, Okayama University Hospital, Okayama, Japan,
-
- Asahara Takashi
- Department of Radiological Technology, Faculty of Health Sciences, Okayama University, Okayama, Japan,
-
- Otsuka Fumio
- Department of General Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan,
-
- Maeda Yoshinobu
- Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan,
-
- Hiraki Takao
- Department of Radiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan
この論文をさがす
説明
<p>This study retrospectively evaluated the computed tomography (CT) findings of idiopathic multicentric Castleman disease (iMCD) at a single center and compared the CT findings of iMCD-TAFRO with those of iMCD-non-TAFRO. CT images obtained within 30 days before diagnostic confirmation were reviewed for 20 patients with iMCD (8 men and 12 women, mean age 52.8 ± 12.3 years, range 25–74 years). Twelve patients were diagnosed with iMCD-TAFRO, five with iMCD-idiopathic plasmacytic lymphadenopathy, and three with iMCD-not otherwise specified. CT images revealed anasarca and lymphadenopathy in all 20 patients. The iMCD-TAFRO group showed significantly higher frequencies of ascites (100% vs. 37.5%, P = 0.004), gallbladder wall edema (75.0% vs. 12.5%, P = 0.020), periportal collar (91.7% vs. 25.0%, P = 0.004), and anterior mediastinal lesions (non-mass-forming infiltrative lesions) (66.7% vs. 12.5%, P = 0.028). Para-aortic edema tended to be more frequent in patients with the iMCD-TAFRO group (83.3% vs. 37.5%, P = 0.062), while the absence of anterior mediastinal lesions tended to be more frequent in the iMCD-non-TAFRO group (16.7% vs. 62.5%, P = 0.062). These CT findings may have clinical implications for improving the accuracy and speed of iMCD diagnosis and differentiating iMCD-TAFRO from other subtypes.</p>
収録刊行物
-
- Journal of Clinical and Experimental Hematopathology
-
Journal of Clinical and Experimental Hematopathology 64 (4), 292-296, 2024-12-25
一般社団法人 日本リンパ腫学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390584099501917312
-
- NII書誌ID
- AA11556796
-
- ISSN
- 18809952
- 13464280
-
- PubMed
- 39721711
-
- 本文言語コード
- en
-
- 資料種別
- journal article
-
- データソース種別
-
- JaLC
- IRDB
- Crossref
- PubMed
- KAKEN
-
- 抄録ライセンスフラグ
- 使用不可